Predicting risk of adverse drug reactions in older adults
Reads0
Chats0
TLDR
Good clinical practice for detecting and predicting ADRs in vulnerable patients includes detailed documentation and regular review of prescribed and over-the-counter medications through standardized medication reconciliation.Abstract:
Adverse drug reactions (ADRs) are common in older adults, with falls, orthostatic hypotension, delirium, renal failure, gastrointestinal and intracranial bleeding being amongst the most common clinical manifestations. ADR risk increases with age-related changes in pharmacokinetics and pharmacodynamics, increasing burden of comorbidity, polypharmacy, inappropriate prescribing and suboptimal monitoring of drugs. ADRs are a preventable cause of harm to patients and an unnecessary waste of healthcare resources. Several ADR risk tools exist but none has sufficient predictive value for clinical practice. Good clinical practice for detecting and predicting ADRs in vulnerable patients includes detailed documentation and regular review of prescribed and over-the-counter medications through standardized medication reconciliation. New medications should be prescribed cautiously with clear therapeutic goals and recognition of the impact a drug can have on multiple organ systems. Prescribers should regularly review medication efficacy and be vigilant for ADRs and their contributory risk factors. Deprescribing should occur at an individual level when drugs are no longer efficacious or beneficial or when safer alternatives exist. Inappropriate prescribing and unnecessary polypharmacy should be minimized. Comprehensive geriatric assessment and the use of explicit prescribing criteria can be useful in this regard.read more
Citations
More filters
Journal ArticleDOI
Machine learning workflow to enhance predictions of Adverse Drug Reactions (ADRs) through drug-gene interactions: application to drugs for cutaneous diseases
TL;DR: A novel literature-mining framework for enhancing the predictions of DDIs and ADR types by integrating drug-gene interactions (DGIs) and successfully predict previously known ADRs for drugs prescribed to cutaneous diseases, and is also able to identify promising new ADRs.
Journal ArticleDOI
Identification and management of frailty in the primary care setting
TL;DR: Frailty is a dynamic state of heightened vulnerability to stressors that places individuals at risk for adverse health outcomes, including falls, disability, admission to hospital, and more.
Journal ArticleDOI
Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?
TL;DR: The current comprehension of the relationship of the microbiome, host biology, and pharmaceutical agents such as cardiovascular drugs, analgesics, and chemotherapeutic agents to human disease and treatment outcomes is presented.
Journal ArticleDOI
What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects
Rike van Eekeren,Leàn Rolfes,Andries S. Koster,Lara Magro,Gurumurthy Parthasarathi,Hussain Al Ramimmy,Tim Schutte,Daisuke Tanaka,Eugène van Puijenbroek,Linda Härmark +9 more
TL;DR: The basis of and outline for the WHO PV core curriculum for university teaching are addressed and it is expected that PV competencies for students are vital for their contribution to safe use of medicines in the future.
Journal ArticleDOI
Development of a standardized chart review method to identify drug‐related hospital admissions in older people
Stefanie Thevelin,Anne Spinewine,Jean-Baptiste Beuscart,Benoît Boland,Benoît Boland,Sophie Marien,Sophie Marien,Fanny Vaillant,Ingeborg Wilting,Ariël M. Vondeling,Carmen Floriani,Claudio Schneider,Jacques Donzé,Jacques Donzé,Jacques Donzé,Nicolas Rodondi,Shane Cullinan,Shane Cullinan,Denis O'Mahony,Olivia Dalleur,Olivia Dalleur +20 more
TL;DR: This work aimed to develop a standardized chart review method to identify drug‐related hospital admissions (DRA) in older people caused by non‐preventable adverse drug reactions and preventable medication errors including overuse, underuse and misuse of medications.
References
More filters
Journal ArticleDOI
A method for estimating the probability of adverse drug reactions
Claudio A. Naranjo,Usoa E. Busto,Edward M. Sellers,Paul Sandor,I Ruiz,E A Roberts,E Janecek,Domecq C,David J. Greenblatt +8 more
TL;DR: It was shown that the ADR probability scale has consensual, content, and concurrent validity and may be applicable to postmarketing drug surveillance.
Journal ArticleDOI
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
TL;DR: The incidence of serious and fatal adverse drug reactions in US hospitals was found to be extremely high, and data suggest that ADRs represent an important clinical issue.
Journal ArticleDOI
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Munir Pirmohamed,Sally James,Shaun Meakin,Chris D. Green,A Scott,Tom Walley,Keith Farrar,B. Kevin Park,Alasdair Breckenridge +8 more
TL;DR: The burden ofADRs on the NHS is high, accounting for considerable morbidity, mortality, and extra costs, and measures need to be put into place to reduce the burden of ADRs and thereby further improve the benefit:harm ratio of the drugs.
Journal ArticleDOI
Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.
Donna M. Fick,James W. Cooper,William E. Wade,Jennifer L. Waller,J. Ross Maclean,Mark H. Beers +5 more
TL;DR: The application of the Beers criteria and other tools for identifying potentially inappropriate medication use will continue to enable providers to plan interventions for decreasing both drug-related costs and overall costs and thus minimize drug- related problems.
Journal ArticleDOI
Adverse drug reactions: definitions, diagnosis, and management.
TL;DR: An adverse drug reaction is an appreciably harmful or unpleasant reaction, resulting from an intervention related to the use of a medicinal product, which predicts hazard from future administration and warrants prevention or specific treatment, or alteration of the dosage regimen, or withdrawal of the product.